These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31958096)

  • 1. The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.
    Zhang L; Zhang L; Li Y; Li L; Melchiorsen JU; Rosenkilde M; Hölscher C
    J Parkinsons Dis; 2020; 10(2):523-542. PubMed ID: 31958096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.
    Feng P; Zhang X; Li D; Ji C; Yuan Z; Wang R; Xue G; Li G; Hölscher C
    Neuropharmacology; 2018 May; 133():385-394. PubMed ID: 29462693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
    Yuan Z; Li D; Feng P; Xue G; Ji C; Li G; Hölscher C
    Eur J Pharmacol; 2017 Oct; 812():82-90. PubMed ID: 28666800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
    Ji C; Xue GF; Lijun C; Feng P; Li D; Li L; Li G; Hölscher C
    Brain Res; 2016 Mar; 1634():1-11. PubMed ID: 26453833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
    Jalewa J; Sharma MK; Gengler S; Hölscher C
    Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
    Salles GN; Calió ML; Hölscher C; Pacheco-Soares C; Porcionatto M; Lobo AO
    Neuropharmacology; 2020 Jan; 162():107813. PubMed ID: 31628935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.
    Cao L; Li D; Feng P; Li L; Xue GF; Li G; Hölscher C
    Neuroreport; 2016 Apr; 27(6):384-91. PubMed ID: 26918675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model.
    Zhang LY; Jin QQ; Hölscher C; Li L
    Neural Regen Res; 2021 Aug; 16(8):1660-1670. PubMed ID: 33433498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat.
    Han L; Hölscher C; Xue GF; Li G; Li D
    Neuroreport; 2016 Jan; 27(1):23-32. PubMed ID: 26555034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease.
    Yang X; Feng P; Ji R; Ren Y; Wei W; Hölscher C
    Expert Opin Ther Targets; 2022 May; 26(5):445-460. PubMed ID: 35584372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson's disease model.
    Li T; Tu L; Gu R; Yang XL; Liu XJ; Zhang GP; Wang Q; Ren YP; Wang BJ; Tian JY
    Life Sci; 2020 Sep; 256():117824. PubMed ID: 32445758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.
    Zhang L; Zhang L; Li L; Hölscher C
    J Parkinsons Dis; 2019; 9(1):157-171. PubMed ID: 30741689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model.
    Zhang L; Zhang L; Li L; Hölscher C
    Neuropeptides; 2018 Oct; 71():70-80. PubMed ID: 30017231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GLP-1/GIP dual-receptor agonist DA5-CH inhibits the NF-κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP-1 single-receptor agonist NLY01.
    Lv M; Xue G; Cheng H; Meng P; Lian X; Hölscher C; Li D
    Brain Behav; 2021 Aug; 11(8):e2231. PubMed ID: 34125470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.
    Hölscher C
    Neuropharmacology; 2018 Jul; 136(Pt B):251-259. PubMed ID: 29402504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
    Shi L; Zhang Z; Li L; Hölscher C
    Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.
    Kopp KO; Li Y; Glotfelty EJ; Tweedie D; Greig NH
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Liu W; Jalewa J; Sharma M; Li G; Li L; Hölscher C
    Neuroscience; 2015 Sep; 303():42-50. PubMed ID: 26141845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
    Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
    J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.